General Information of MIC (ID: MIC00216)
MIC Name Bifidobacterium animalis subsp. lactis (actinobacteria)
MIC Synonyms Bifidobacterium lactis
Body Site Gut
Lineage Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Bifidobacteriales
Family: Bifidobacteriaceae
Genus: Bifidobacterium
Species: Bifidobacterium animalis subsp. lactis
Oxygen Sensitivity Obligate anaerobe
Microbial Metabolism Saccharolytic, Fermentative
Gram Positive
Host Relationship Probiotic
Genome Size (bp) 1932693
No. of Coding Genes 1536
No. of Non-Coding Genes 65
No. of Small Non-Coding Genes 65
No. of Gene Transcripts 1601
No. of Base Pairs 1938624
Description Many strains of Bifidobacterium animalis subsp. lactis are considered health-promoting probiotic microorganisms and are commonly formulated into fermented dairy foods.
External Links Taxonomy ID
302911
Genome Assembly ID
ASM81805v1
GOLD Organism ID
Go0001037
Disease Relevance
          Inflammatory bowel disease  [ICD-11: DD72]
             Description The health-promoting properties of the commercialized strain Bifidobacterium animalis ssp. lactis Bb-12 (Bb-12) were associated with prevention of inflammatory bowel disease. [1]
          Irritable bowel syndrome  [ICD-11: DD91]
             Description Bifidobacterium lactis was associated with chronic constipation. [2]
Host Genetic Factors (HGFs)
          rs651821
             HGF ID HGF1924 HGF Info       Class Single Nucleotide Polymorphism: Prime UTR variant (SNP-PV)
             Description The APOA5 SNP rs651821 might be an important host genetic factor in determining the abundances of the health-promoting Bifidobacterium bacteria and the taxa to which this genus belongs. [3]
          rs5743399
             HGF ID HGF1974 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs5743399 SNP showed an interaction with HN019 in that children with this variant who were in the HN019 treatment group showed a significantly reduced risk of eczema (p-value=0.0070). [4]
          rs3815735
             HGF ID HGF1320 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs3815735 SNP showed an interaction with HN019 in that children with this variant who were in the HN019 treatment group showed a significantly reduced risk of eczema (p-value=0.0084). [4]
          rs2107356
             HGF ID HGF1724 HGF Info       Class Single Nucleotide Polymorphism: Upstream variant (SNP-UV)
             Description The rs2107356 SNP showed an interaction with HN019 in that children with this variant who were in the HN019 treatment group showed a significantlyreduced risk of eczema (p-value=0.0127). [4]
Host Immune Factors (HIFs)
          C-C motif chemokine 22
             HIF ID HIFM0025 HIF Info       Class Antimicrobial peptide (AMP)
             Description The abundance of circulating CCL22 was lower in the group supplemented with Bifidobacterium animalis subsp.lactis. [5]
          Human beta-defensin 1
             HIF ID HIFM0090 HIF Info       Class Antimicrobial peptide (AMP)
             Description Bifidobacterium animalis subsp. lactis HN019 showed increased susceptibility to 5 and 10 mg/mL of hBD-1 in the presence of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and Bifidobacterium animalis subsp. lactis HN019 were increased killed more than 20% by the concentration of hBD-1. [6]
          CD19+ B cells
             HIF ID HIFC0092 HIF Info       Class B cells (BCs)
             Description Bifidobacterium animalis subsp.lactis Bi-07 supplementation reduced the expression of CD19+B cells. [7]
          Interferon-12 subunit alpha
             HIF ID HIFM0130 HIF Info       Class Cytokine (Cyt)
             Description Bifidobacterium animalis subsp.lactis HN019 promoted a Th1 immune response through an increase expression in IL-12. [8]
          Interleukin-23 subunit alpha
             HIF ID HIFM0144 HIF Info       Class Cytokine (Cyt)
             Description Bifidobacterium animalis subsp.lactis HN019 promote a Th1immune response through an increase expression in IL-23. [8]
          Immunoglobulin G
             HIF ID HIFM0270 HIF Info       Class Immunoglobulin (Ig)
             Description The abundance of Bifidobacterium animalis subsp.lactis HN019 is associated with IgG immune response. [8]
          CD4+ helper T cells
             HIF ID HIFC0068 HIF Info       Class T cells (TCs)
             Description Bifidobacterium animalis subsp. lactis has the intrinsic ability to promote a Th1 immune response through an increase in IL-12/IL-23. [8]
Environmental Factor(s)
             Disbiome ID
      764
             gutMDisorder ID
      gm0107
References
1 Effect of galactooligosaccharides and Bifidobacterium animalis Bb-12 on growth of Lactobacillus amylovorus DSM 16698, microbial community structure, and metabolite production in an in vitro colonic model set up with human or pig microbiota. FEMS Microbiol Ecol. 2013 Apr;84(1):110-23. doi: 10.1111/1574-6941.12041. Epub 2012 Dec 17.
2 Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation. Aliment Pharmacol Ther. 2019 Feb;49(3):251-264. doi: 10.1111/apt.15073. Epub 2018 Dec 25.
3 The effect of heritability and host genetics on the gut microbiota and metabolic syndrome.Gut. 2017 Jun;66(6):1031-1038. doi: 10.1136/gutjnl-2015-311326. Epub 2016 Apr 6.
4 Differential modification of genetic susceptibility to childhood eczema by two probiotics.Clin Exp Allergy. 2014 Oct;44(10):1255-65. doi: 10.1111/cea.12394.
5 Integrated Role of Bifidobacterium animalis subsp. lactis Supplementation in Gut Microbiota, Immunity, and Metabolism of Infant Rhesus Monkeys.mSystems. 2016 Nov 29;1(6):e00128-16. doi: 10.1128/mSystems.00128-16. eCollection 2016 Nov-Dec.
6 Antimicrobial activity of human -defensins against lactic acid bacteria.Nat Prod Res. 2015;29(22):2164-6. doi: 10.1080/14786419.2014.996754. Epub 2015 Jan 6.
7 Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.Br J Nutr. 2014 Jun 14;111(11):1945-56. doi: 10.1017/S0007114513004261. Epub 2014 Mar 24.
8 Investigation of the immunomodulatory effects of Lactobacillus casei and Bifidobacterium lactis on Helicobacter pylori infection. Helicobacter. 2008 Jun;13(3):183-90. doi: 10.1111/j.1523-5378.2008.00595.x.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.